ストックスクリーナーアプリを入手
2.17
1.36%
-0.03
アフターアワーズ：
2.04
-0.13
-5.99%
Calcimedica Inc (CALC) 最新ニュース
CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk - TipRanks
CalciMedica (NASDAQ: CALC) fixes one Nasdaq warning but faces a $1 price deadline - Stock Titan
Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move - GuruFocus
CalciMedica To Carry Out 1-for-5 Reverse Stock Split On August 31st, 2026 - Moomoo
CalciMedica executes 1-for-5 reverse stock split - Investing.com
CalciMedica Inc (CALC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
CalciMedica (CALC) Quarter in Focus: The Available Earnings Metric Delivers a Beat; Closing Move: Shares Move Higher 5.68% for the Current SessionEarnings Call Transcript - vinanet.vn
Stonepine takes CalciMedica (CALC) stake via capped warrants - Stock Titan
Alafi Capital updates CalciMedica (NASDAQ: CALC) stake after multimillion-warrant grant - Stock Titan
CalciMedica (CALC) grants director 10,000 stock options through 2036 - Stock Titan
CalciMedica (NASDAQ: CALC) awards director 10,000 options at $0.61 - Stock Titan
CalciMedica (CALC) grants director 10,000 stock options at $0.61 - Stock Titan
CalciMedica (CALC) director granted 2.9M-share warrants with 9.99% cap - Stock Titan
CalciMedica (NASDAQ: CALC) grants FDA-linked warrants capped at 19.99% stake - Stock Titan
CalciMedica (NASDAQ: CALC) CEO granted new stock warrants - Stock Titan
CalciMedica (NASDAQ: CALC) has 9.99% holder blocked from using more warrants - Stock Titan
CalciMedica (CALC) Financial Update: EPS Lands Above Forecast in the Current Update; The Stock Ends Down 4.88% in the Current UpdateProfit Inflection Point - vinanet.vn
ARMISTICE CAPITAL, LLC Acquires Significant Stake in CalciMedica Inc (CALC) - GuruFocus
CalciMedica Shareholders Approve Reverse Stock Split - Minichart
CalciMedica Shareholders Approve Key Equity and Governance Changes - TipRanks
CalciMedica (NASDAQ: CALC) holders back reverse split and warrant deals - Stock Titan
Guggenheim initiates CalciMedica stock with buy rating on drug potential - Investing.com
Guggenheim initiates CalciMedica stock coverage with buy rating By Investing.com - Investing.com India
Guggenheim initiates CalciMedica stock coverage with buy rating - Investing.com
CalciMedica (CALC) Edges Higher by 2.71% as Shares Consolidate Between $0.65 and $0.71TRIN Signal - dars.gov.et
Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan
Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan
CALC Q1 2026 Earnings: EPS of $0.30 Crushes Estimates, Stock Advances 6%Revenue Miss Report - vinanet.vn
CALC Q1 2026 Earnings: EPS Swings to Profit With 205.04% SurpriseEarnings Sentiment Score - vinanet.vn
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com Canada
Price to book forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
Price to book forward of CalciMedica, Inc. – BOATS:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – NASDAQ:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – BOATS:CALC - TradingView
CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 8K CalciMedica Inc For: 11 August By Investing.com - Investing.com UK
CalciMedica, Inc. 2Q 2026: Net loss $7.7M, EPS $(0.45) — 10-Q Summary - TradingView
CalciMedica (CALC) cuts expenses, raises $15M but flags going concern risk - Stock Titan
CalciMedica Releases Q2 2026 Financial Results - AlphaStreet
CalciMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Yahoo Finance
CalciMedica Secures Up To $49 Million Private Placement To Advance Pulmonary Hypertension Pipeline - Minichart
CalciMedica Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CalciMedica Q2 FY26 net loss widens to $7.65 million - Bitget
CalciMedica stock gains 6% despite earnings miss on pulmonary trial By Investing.com - Investing.com South Africa
CalciMedica stock gains 6% despite earnings miss on pulmonary trial - Investing.com
CalciMedica reports Q2 2026 results: $18.6M cash, net loss $7.7M; financing to fund PH programs - TradingView
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - Moomoo
CalciMedica Q2 Results: EPS misses estimate, losses widen 12.5% YoY - scanx.trade
CalciMedica Inc (CALC) Stock News Today - TradingKey
CalciMedica Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
12 Health Care Stocks Moving In Monday's Intraday SessionUniverse Pharmaceuticals (NASDAQ:UPC), SL Sci - benzinga.com
CalciMedica Inc (CALC:UR): Stock Price, Quote and News - bnnbloomberg.ca
CalciMedica aligns with FDA on acute pancreatitis trial design By Investing.com - Investing.com Canada
CalciMedica aligns with FDA on acute pancreatitis trial design - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market SessionAutonomix Medical (NASDAQ:AMIX), CalciMe - benzinga.com
CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CalciMedica Inc (CALC) Institutional Confidence - TradingKey
CALC|CalciMedica Inc|Price:2.150|Chg%:-0.050 - tradingkey.com
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):